Logo-apb
Adv Pharm Bull. 2024;14(1): 48-66. doi: 10.34172/apb.2024.016
PMID: 38585451        PMCID: PMC10997935

Review Article

Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics

Soheil Mehrdadi 1 * ORCID

Cited by CrossRef: 2


1- Veider F, To D, Saleh A, Laffleur F, Kali G, Hense D, Strube O, Bernkop-Schnürch A. Charge-converting nanocarriers: Phosphorylated polysaccharide coatings for overcoming intestinal barriers. International Journal of Biological Macromolecules. 2024;281:136308 [Crossref]
2- Gisela Bevilacqua Rolfsen F, Guedmiller Souza D, Ariana D, Livia Rodrigues F, Eryvaldo Socrates Tabosa D, Fábio D, Anselmo Gomes D. Dimethyl Fumarate Sterically Stabilized Solid Lipid Nanoparticles. Physicochemical properties and in vitro drug release. Int J Nanomater Nanotechnol Nanomed. 2025;11(1):015 [Crossref]